• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[动脉瘤性出血中的止血过程]

[Hemostatic processes in aneurysmal hemorrhages].

作者信息

Hindersin P, Heidrich R

出版信息

Psychiatr Neurol Med Psychol (Leipz). 1977 Mar;29(3):129-44.

PMID:877166
Abstract

Pathogenetic, diagnostic, and therapeutic problems and questions associated with ruptured cerebral aneurysms assume good knowledge of hemostatic processes. The three factors affecting hemostasia, namely, vasoactive, coagulative, and fibrinolytic risk factors in the blood, cerebro--spinal fluid, and at the site of damage to the vessel wall, are discussed withparticular reference to a thrombosing aneurysm. In the case of secondary hemorrhages it is necessary to determine the cause or pathogenesis, respectively, of the disturbance of coagulation or increase in fibrinolysis in order to be able to take suitable therapeutic measures and reduce the risk of secondary bleeding occurring within the first critical weeks after aneurysmal rupture.

摘要

与破裂性脑动脉瘤相关的发病机制、诊断和治疗问题,需要对止血过程有充分的了解。本文将特别结合血栓形成性动脉瘤,讨论影响止血的三个因素,即血液、脑脊液及血管壁损伤部位的血管活性、凝血和纤维蛋白溶解风险因素。对于继发性出血,有必要分别确定凝血障碍或纤维蛋白溶解增加的原因或发病机制,以便能够采取适当的治疗措施,并降低动脉瘤破裂后最初关键几周内发生继发性出血的风险。

相似文献

1
[Hemostatic processes in aneurysmal hemorrhages].[动脉瘤性出血中的止血过程]
Psychiatr Neurol Med Psychol (Leipz). 1977 Mar;29(3):129-44.
2
[Current status of intrathecal antifibrinolytic therapy with p-aminomethylbenzoic acid (PAMBA) in subarachnoid hemorrhages].
Psychiatr Neurol Med Psychol (Leipz). 1985 Dec;37(12):686-9.
3
[Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].[颅内出血与止血。通过测定和随访凝血激活产物对颅内出血患者进行监测]
Infusionsther Transfusionsmed. 1994 Aug;21(4):244-50.
4
Streptokinase clot lysis time in patients with ruptured intracranial aneurysms.颅内动脉瘤破裂患者的链激酶凝血溶解时间
J Neurosurg. 1974 Apr;40(4):499-503. doi: 10.3171/jns.1974.40.4.0499.
5
[Disturbances of the hemostatic system in patients with aneurysmal subarachnoid hemorrhage].[动脉瘤性蛛网膜下腔出血患者止血系统的紊乱]
Zh Vopr Neirokhir Im N N Burdenko. 2018;82(4):109-116.
6
[Prediction of recurrent hemorrhages from ruptured arterial aneurysms in the acute period].[破裂性动脉瘤急性期再出血的预测]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1986;86(9):1281-4.
7
The effect of tranexamic acid on bleeding time and haemostasis.
Neurochirurgia (Stuttg). 1991 Sep;34(5):141-3. doi: 10.1055/s-2008-1052074.
8
[Coagulation physiological controls in subarachnoid hemorrhages and their therapeutic implications].[蛛网膜下腔出血中的凝血生理控制及其治疗意义]
Psychiatr Neurol Med Psychol (Leipz). 1982 Apr;34(4):236-41.
9
Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.辛伐他汀对动脉瘤性蛛网膜下腔出血患者的生物学效应:一项双盲、安慰剂对照的随机试验。
J Cereb Blood Flow Metab. 2009 Aug;29(8):1444-53. doi: 10.1038/jcbfm.2009.59. Epub 2009 May 20.
10
Monitoring antifibrinolytic therapy in subarachnoid hemorrhage.蛛网膜下腔出血中抗纤溶治疗的监测
J Neurosurg. 1973 Mar;38(3):339-44. doi: 10.3171/jns.1973.38.3.0339.

引用本文的文献

1
Clinical pharmacokinetics of cerebrospinal fluid.脑脊液的临床药代动力学
Clin Pharmacokinet. 1982 Jul-Aug;7(4):312-35. doi: 10.2165/00003088-198207040-00003.
2
Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid.通过鞘内注射对氨基甲基苯甲酸进行蛛网膜下腔出血的抗纤溶治疗。
J Neurol. 1978 Sep 12;219(1):83-5. doi: 10.1007/BF00313371.